BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27388776)

  • 1. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy.
    Moratalla A; Ampuero J; Bellot P; Gallego-Durán R; Zapater P; Roger M; Figueruela B; Martínez-Moreno B; González-Navajas JM; Such J; Romero-Gómez M; Francés R
    Liver Int; 2017 Feb; 37(2):212-223. PubMed ID: 27388776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of minimal hepatic encephalopathy in cirrhotic patients.
    Maldonado-Garza HJ; Vázquez-Elizondo G; Gaytán-Torres JO; Flores-Rendón AR; Cárdenas-Sandoval MG; Bosques-Padilla FJ
    Ann Hepatol; 2011 Jun; 10 Suppl 2():S40-4. PubMed ID: 22228880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.
    Zullo A; Rinaldi V; Meddi P; Hassan C; Winn S; Attili AF
    Am J Gastroenterol; 1999 Aug; 94(8):2214-8. PubMed ID: 10445552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
    Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
    J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.
    Romero-Gómez M; Córdoba J; Jover R; del Olmo JA; Ramírez M; Rey R; de Madaria E; Montoliu C; Nuñez D; Flavia M; Compañy L; Rodrigo JM; Felipo V
    Hepatology; 2007 Apr; 45(4):879-85. PubMed ID: 17393525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P; Sharma BC
    Saudi J Gastroenterol; 2012; 18(3):168-72. PubMed ID: 22626795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
    Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients.
    Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Ferrandez A; Rodrigo JM; Felipo V
    J Mol Med (Berl); 2007 Mar; 85(3):237-45. PubMed ID: 17216205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    J Hepatol; 2007 Jul; 47(1):67-73. PubMed ID: 17459511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
    Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
    J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery.
    Özbaş B; Keskin O; Hecker H; Karahan I; Özbaş C; Kalkan Ç; Kartal A; Önder FO; Öncü BK; Gençdal G; Akyildiz M; Günşar F; Idilman R; Weissenborn K; Özütemiz Ö; Yurdaydin C
    Hepatol Int; 2021 Dec; 15(6):1442-1455. PubMed ID: 34085147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC
    Saudi J Gastroenterol; 2010; 16(3):181-7. PubMed ID: 20616413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
    Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.